期刊文献+

我院急诊超说明书用药情况调查分析 被引量:3

Investigation and analysis of off-label drug uses of the emergency department in our hospital
下载PDF
导出
摘要 目的:对本院急诊超说明书用药情况进行分析,为临床合理用药和法律法规制定提供参考。方法:分层随机抽取本院2018年1—12月急诊处方,对超说明书用药发生率、超说明书用药类型、年龄段和药物种类进行统计分析。结果:本院急诊超说明书用药发生率按处方数和用药记录数计分别为25.50%和12.78%。超说明书用药类型包括超用法用量(53.36%)、超适应人群(21.78%)、超适应症(18.57%)和超给药途径(6.29%)。其中发生率排前两位的年龄段为婴幼儿和儿童;发生率居前两位的药物种类为抗感染药和呼吸系统用药。结论:本院急诊超说明书用药现象基本处于合理范围,仍需从多方面对超说明书用药现象进行规范。 Objective: To provide reference for clinical rational drug use and legal regulations, we investigated the off-label drug uses in emergency department of our hospital. Methods: The prescriptions were randomly selected from emergency department of our hospital during January to December 2018.The prescriptions of off-label drug use were picked out and statistically analyzed in the type of off-label drug use, the relationship of different age groups with various drugs. Results: According to the number of prescriptions and medication records, the incidences of off-label drug use were 25.50% and 12.78%, respectively. The four reasons for off-label drug use were over usage and dosage (53.36%), over applicable people (21.78%), over indications ( 18.57%) and over contraindications (6.29%). The top two groups of off-label drug use were infants and children. Main drugs in off-label use involved anti-infective medicines and respiratory system medicines. Conclusion: The phenomenon of off-label drug use in the emergency department of our hospital is basically in a reasonable range. It is necessary to regulate the phenomenon of off-label drug use in many aspects.
作者 王旭 Wang Xu(The Second Hospital of Tianjin Medical University, Tianjin 300201)
出处 《天津药学》 2019年第5期36-39,共4页 Tianjin Pharmacy
关键词 超说明书用药 急诊 合理用药 off-label drug use emergency department rational drug use
  • 相关文献

参考文献11

二级参考文献64

  • 1Soumana C Nasser,Jeanette G Nassif,Hani I Dimassi.Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients[J].World Journal of Gastroenterology,2010,16(8):982-986. 被引量:23
  • 2于星,郭咸希,杨健,唐荣福.从一起“试验性治疗”诉讼案看超说明书范围用药的潜在风险[J].中国药物警戒,2011,8(1):32-33. 被引量:16
  • 3Stafford RS. Regulating off-label drug use: rethinking therole of the FDA[J]. N Engl J Med, 2008,358 (14) : 1 427.
  • 4Jain S, Saini SS, Chawla D, et al. Off-label use of drugs in neonatal intensive care units[J]. Indian Pediatr, 2014, 51(8) :644.
  • 5American Society of Hospital Pharmacists. ASHP statem- ent on the use of medications for unlabeled uses[J]. Am J Hosp Pharm, 1992,49(8) :2 006.
  • 6广东省药学会.药品未注册用法专家共识[S].2010-03-18.
  • 7Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children[J]. Arch Pediatr Adolesc Med, 2007,161(3) :282.
  • 8Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK: an analysis of 18 000 pre- scriptions in Liverpool Women' s Hospital[J]. Int J Pharm Pract, 2010,18(4) : 226.
  • 9Weeks A, Fandes A. Misoprostol in obstetrics and gyne- cology[J]. Int J Gynecol Obstet, 2007,99 (Suppl 2 ) : S 156.
  • 10Fairman KA, Curtiss FR. Regulatory actions on the off- label use of prescription drugs: ongoing controversy and contradiction in 2009 and 2010[J]. J Manag Care Pharm, 2010,16(8) :829.

共引文献255

同被引文献53

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部